Abstract
The gold standard for determining the efficacy of biomedical therapies is the detection of a significant difference between the therapeutic effects of an active pharmacological agent or procedure and a matched inert placebo in a randomized controlled trial.
Detecting this difference has become a challenge for medicine, especially for outcomes that are based